smallcaps
Resonance Health Improves Cash Position as Clinical Trial Pipeline Expands
Resonance Health ASX:RHT generated FY26 cash receipts of $14.3 million and net positive operating cash inflow of $2.9m, recording positive operating cash flow in every quarter of the year.Q4 receipts reached $4.0m and net operating cash inflow was $0.7m, lifting cash at bank to $4.8m at 30 June.Wit…